Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Laboratories’ arm recalling Morphine Sulfate extended-release tablets

Date: 18-11-2024

Dr. Reddy's Laboratories’ US-based subsidiary -- Dr Reddy's Laboratories Inc is recalling 2,040 bottles of 15 mg Morphine Sulfate extended-release tablets due to ‘Failed Impurities/Degradation Specification’. It is also recalling another 532 100-count bottles of the medication in 30 mg strength for the same reason.

Dr Reddy's initiated the Class II nationwide recall on October 22 this year.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.